It has been found that PTPN11 mutations are not limited to adult AML, but are also associated with a range of hematological malignancies, such as JMML, childhood AML, myelodysplastic syndromes, and acute B-lymphocytic leukemia [21,35,36]. Here, PTPN11 is linked to juvenile myelomonocytic leukemia.